Schiff

Move Free Ultra Gummies Type II Collagen + Boron + HA

D
N+ Score66
Collagen & BeautyServing: 1 Gummy(s)Type: Other Combinations

Schiff's Move Free Ultra Gummies offer a combination of ingredients commonly associated with joint health. Each gummy contains a Proprietary Cartilage Blend at 40 mg, 5 mg of Boron Glycinate, and 3.3 mg of Hyaluronic Acid. This product received an N+ Score of 66, earning it a D grade and placing it in the average tier for overall quality. While the label transparency is excellent at 100%, the ingredient adequacy and formula completeness scores of 50% and 33% suggest that some key ingredients may not be present at dosages that research commonly suggests for optimal benefits, particularly for the proprietary blend. This gummy formulation may be suitable for individuals preferring a convenient, chewable option for joint support.

About This Product

Move Free Ultra Gummies Type II Collagen + Boron + HA by Schiff is a collagen & beauty supplement containing 5 active ingredients. It has earned an N+ Score of 66/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (5 ingredients)

IngredientAmountDose Adequacy
Calories10.000 Calorie(s)N/A
Total Carbohydrates3.000 Gram(s)N/A
Hyaluronic Acid3.300 mgN/A
Boron Glycinate5.000 mgN/A
Proprietary Cartilage Blend40.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.